AUDUBON, PA — Globus Medical, Inc. (NYSE: GMED) has finalized its acquisition of Nevro Corp., a leading global medical device company specializing in treatments for chronic pain.
“We are excited to begin the journey of accelerating market penetration of Nevro’s differentiated high-frequency technology and bringing a much-needed treatment option to patients suffering from chronic pain,” said Dan Scavilla, president and CEO of Globus Medical.
The acquisition expands Globus Medical’s presence in the musculoskeletal market, unlocking a $2.5 billion market opportunity. The move adds to its product portfolio and positions the company to redefine the standard of care in neuromodulation and related fields.
Trading of Nevro Corp.’s common stock on the New York Stock Exchange ceased on April 3, 2025. Globus Medical plans to outline the benefits of this strategic acquisition during its upcoming first-quarter earnings conference in May.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.